View Archive »
About The Cover
The cover for issue 8 of Oncotarget features Figure 8, "MLN4924 treatment induces DNA damage by stabilizing CDT1 and accumulates the cells in S phase which are enhanced by MLN4924/cisplatin co-treatment," by Misra, et al.
Table of Contents
EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis
EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis |
|
https://doi.org/10.18632/oncotarget.27374
Raphaël Bergès,
Aurélie Tchoghandjian,
Arnauld Sergé,
Stéphane Honoré,
Dominique Figarella-Branger,
Felix Bachmann,
Heidi A. Lane,
and Diane Braguer
|
| 759-774 |
Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma
Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma |
|
https://doi.org/10.18632/oncotarget.27437
Sonali Joshi,
Shawn Campbell,
Jeong Y. Lim,
Shannon McWeeney,
Adam Krieg,
Yukie Bean,
Nadja Pejovic,
Paulette Mhawech-Fauceglia,
and Tanja Pejovic
|
| 775-783 |
Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment
Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment |
|
https://doi.org/10.18632/oncotarget.27485
Shrilekha Misra,
Xiaoli Zhang,
Nissar Ahmad Wani,
Steven Sizemore,
and Alo Ray
|
| 784-800 |
SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism
SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism |
|
https://doi.org/10.18632/oncotarget.27486
Valeria Santoro,
Ilya Kovalenko,
Kim Vriens,
Stefan Christen,
Andreas Bernthaler,
Andrea Haegebarth,
Sarah-Maria Fendt,
and Sven Christian
|
| 801-812 |
Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer
Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27491
Atsushi Tanaka,
Yihua Zhou,
Jinru Shia,
Fiona Ginty,
Makiko Ogawa,
David S. Klimstra,
Ronald C. Hendrickson,
Julia Y. Wang,
and Michael H. Roehrl
|
| 813-824 |
Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis |
|
https://doi.org/10.18632/oncotarget.27370
Minzhi Hou,
Zhiqiang Cheng,
Hongwei Shen,
Shanyang He,
Yang Li,
Yunping Pan,
Chongjin Feng,
Xinlin Chen,
Yang Zhang,
Millicent Lin,
Liantang Wang,
and Zunfu Ke
|
| 825-826 |
Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1 |
|
https://doi.org/10.18632/oncotarget.27484
Linda Pudelko,
Pegah Rouhi,
Kumar Sanjiv,
Helge Gad,
Christina Kalderén,
Andreas Höglund,
Massimo Squatrito,
Alberto J. Schuhmacher,
Steven Edwards,
Daniel Hägerstrand,
Ulrika Warpman Berglund,
Thomas Helleday,
and Lars Bräutigam
|
| 827-827 |
